Back to search results
NCT07041125

Concomitant LAAC/AF Ablation (Watchman FLX Pro)

Completed
Not specifiedAges 18+Observational
Heart Rhythm Clinical and Research Solutions, LLC
~122 participants
Updated 2026-08-31 on ClinicalTrials.gov
What's tested:Watchman FLX™ Pro device.

At a glance

Recruiting sites
0 of 15 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The occurrence of events between the time of implant and within 7 days following the procedure
Measured over 12 months

Conditions

PFA Ablation and LAAC Procedures

Explore related trials

Atrial Fibrillation

NCT07041125

Where you'd take part

This study runs at 15 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Allegheny General Hospital

    Pittsburgh, Pennsylvaniano site contact published

  • Arrhythmia Center of South Florida

    Delray Beach, Floridano site contact published

  • Arrhythmia Institute at Grandview

    Birmingham, Alabamano site contact published

  • Ascension St Vincent -Indianapolis Ascension Health

    Indianapolis, Indianano site contact published

  • Ascension St. Vincent's Jacksonville

    Jacksonville, Floridano site contact published

  • California Pacific Medical Center Sutter Health

    San Francisco, Californiano site contact published

  • Chippenham Hospital)

    Richmond, Virginiano site contact published

  • HCA Research Institute- Mercy Hospital

    Miami, Floridano site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients who are determined by physicians to be eligible for LAAC
Patients whose LAAC with Watchman FLX Pro procedures are performed concomitant following AF ablation procedure
Willing and able to provide additional informed consent to the sub-study (unless waiver of consent is obtained)

Exclusion

Patients who are participating in other DISRUPT-AF sub-studies

What this trial measures

  • The occurrence of events between the time of implant and within 7 days following the procedure12 months

    AF ablation safety will be compared between the concomitant procedures and standalone AF ablation cohort. and LAAC procedure safety will be compared between the concomitant procedures and standalone LAAC cohort.